-+ 0.00%
-+ 0.00%
-+ 0.00%

Korsana Biosciences Q3 EPS $(3.19) Misses $(0.85) Estimate

Benzinga·11/05/2026 12:39:27
Listen to the news
Korsana Biosciences (NASDAQ:KRSA) reported quarterly losses of $(3.19) per share which missed the analyst consensus estimate of $(0.85) by 275.29 percent. This is a 91.92 percent increase over losses of $(39.49) per share from the same period last year.